CARBON MD
ActiveSummary
CARBON MD has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €205k and a net result of €191k. Equity is growing by ~2.5% per year across the filed fiscal years. Its solvency ranks better than 53% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
83
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency92▼-8
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €17k at 30 days acceptable
Liquidity ample (current ratio 2.64 against 3.81 in 2024; short-term debt: 32.2% and cash: 3% of total assets), and 33.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
66.5%
Return on assets
62%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-06-2026, 60 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
60 d early
2024
34 d early
2023
12 d early
2022
14 d early
2021
19 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€205k▼ 14.9%
2024 · €241k
2021: €155k
2022: €242k
2023: €434k
2024: €241k
2021 → 2025
Total assets
€309k▼ 3.0%
2024 · €318k
2021: €201k
2022: €263k
2023: €533k
2024: €318k
2021 → 2025
Net result
€191k▼ 15.8%
2024 · €227k
2021: €150k
2022: €87k
2023: €192k
2024: €227k
2021 → 2025
Working capital
€163k▼ 21.1%
2024 · €206k
2021: €154k
2022: €241k
2023: €432k
2024: €206k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€155k-€242k▲ 56.0%€434k▲ 79.5%€241k▼ 44.5%€205k▼ 14.9%
Operating result€197k-€116k▼ 41.2%€251k▲ 117%€298k▲ 18.8%€259k▼ 13.0%
Net result€150k-€87k▼ 42.2%€192k▲ 121%€227k▲ 18.2%€191k▼ 15.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 13% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €309k
Fixed assets
€46k ▲ 20.9%
Current assets
€262k ▼ 6.2%
Equity and liabilities €309k
Equity
€205k ▼ 14.9%
Debt
€103k ▲ 34.3%
The debt ratio rises from 24.2% to 33.5%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€265k▼
2024 · €301k
Cash flow
€197k▼
2024 · €230k
Current ratio
2.64▼
2024 · 3.81
Debt / equity
0.50▲
2024 · 0.32
ROE
93.2%▼
2024 · 94.2%
ROA
62.0%▼
2024 · 71.4%
Interest coverage
35.34▼
2024 · 47.71
Debt ≤ 1 year
€99k▲
2024 · €73k
Income taxes
€62k▼
2024 · €70k
Staff costs
€9k▲
2024 · €6k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet
Code20242025
Assets
Total assets20/58€318k€309k▼
Fixed assets21/28€38k€46k▲
Tangible fixed assets22/27€36k€44k▲
Plant, machinery and equipment23€3k€9k▲
Furniture and vehicles24-€6k
Other tangible fixed assets26€33k€30k▼
Financial fixed assets28€3k€3k=
Current assets29/58€280k€262k▼
Amounts receivable within one year40/41€221k€50k▼
Trade receivables40€57k€50k▼
Other amounts receivable41€163k-
Current investments50/53€16k€9k▼
Cash at bank and in hand54/58€40k€9k▼
Deferred charges and accrued income490/1€3k€194k▲
Equity and liabilities
Total equity and liabilities10/49€318k€309k▼
Equity10/15€241k€205k▼
Contributions10/11€5k€5k=
Reserves13€236k€200k▼
Distributable reserves133€236k€200k▼
Amounts payable17/49€77k€103k▲
Amounts payable within one year42/48€73k€99k▲
Trade debts44€3k€4k▲
Suppliers440/4€3k€4k▲
Taxes, remuneration and social security45€14k€7k▼
Taxes450/3€12k€4k▼
Remuneration and social security454/9€3k€4k▲
Other amounts payable47/48€56k€89k▲
Accrued charges and deferred income492/3€4k€4k▲
Income statement
Code20242025
Remuneration, social security and pensions62€6k€9k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€6k▲
Other operating charges640/8€352€552▲
Gross operating margin9900€307k€275k▼
Operating profit (loss)9901€298k€259k▼
Financial income75/76B€5k€2k▼
Recurring financial income75€5k€2k▼
Financial charges65/66B€6k€8k▲
Recurring financial charges65€6k€8k▲
Profit (loss) for the period before taxes9903€297k€254k▼
Income taxes67/77€70k€62k▼
Profit (loss) for the period9904€227k€191k▼
Profit (loss) for the period to be appropriated9905€227k€191k▼
Appropriation of the result
Profit (loss) to be appropriated9906€227k€191k▼
Transfer from equity791/2€420k€227k▼
Transfer to equity691/2€227k€191k▼
To other reserves6921€227k€191k▼
Profit to be distributed694/7€420k€227k▼
Return on contributions (dividend)694€420k€227k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
01-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2021net €227k ▲18.2%
Operating result €298k, net result €227k, both a record.
19-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
17-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €87k ▼42.2%
Net result drops to €87k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity triplescurrent ratio 12.29
Current ratio from 4.38 to 12.29; short-term debt falls from €46k to €21k.
31-12
Financial
Equity above €200kEq €242k ▲56%
2 profitable years in a row build equity to €242k.
12-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zulte · 2 establishment units since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Waalstraat 2479870 ZulteGround area
17.1 ha
Building footprint
2.4 ha
2 parcels, Flanders. Linked by address, not a title deed.
2 establishment units
Waalstraat 247, 9870 Zulte
since 20202.311.347.771
Deltalaan 1, 8800 Roeselare
since 20202.311.349.751
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36017A1048/00B000 | Flanders | 16.7 ha | 1 · 2.4 ha | - |
| 44081C0351/00D000 | Flanders | 3,372 m² | 1 · 208 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 923 EUR awarded · 923 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 923 EUR | 923 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
Kinderarts Yasmina Dejonckheere
BE 0789.637.111
Jabbeke · Eq €206k
DOKTER L.DEVALKENEER KINDERPSYCHIATRIE
BE 0806.582.021
Asse · Eq €205k
RNA BIOCLIN
BE 0628.720.544
Mons · Eq €205k
Dr. Isaline Vaninbroukx, oogheelkunde
BE 0793.989.441
Leuven · Eq €206k
JSB Esthetic
BE 0802.927.495
Perwez · Eq €205k
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,673 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-12-2020
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.